肿瘤手术患者术中失血性休克的短期与长期死亡率及相关因素
这项回顾性研究在癌症转诊中心纳入2013年1月至2018年2月期间因择期或急诊肿瘤手术发生术中失血性休克的84例成人癌症患者,评估30天死亡率和长期生存相关因素。30天死亡率为26%(22例),中位随访20个月(95%CI 15-25个月)期间46%(39例)死亡。多因素logistic回归显示SAPS II评分(OR=1.056,95%CI 1.010-1.1041)、delta SOFA(OR=1.780,95%CI 1.184-2.677)和ISTH-DIC评分(OR=2.705,95%CI 1.108-6.606)与30天死亡率独立相关。Cox多因素分析显示delta SOFA(HR=1.558,95%CI 1.298-1.870)、ISTH-DIC评分(HR=1.381,95%CI 1.049-1.817)、肝功能障碍(HR=7.653,95%CI 2.031-28.842)和Charlson合并症指数(HR=1.330,95%CI 1.041-1.699)与长期死亡率相关。作者认为应评估早期围手术期集束化策略以改善此类患者的生存。
要点
- 肿瘤手术术中失血性休克患者30天死亡率为26%(22/84),长期随访46%(39例)死亡。
- ICU前3天器官功能障碍恶化(delta SOFA)与30天死亡率(OR=1.780,95%CI 1.184-2.677)和长期死亡率(HR=1.558,95%CI 1.298-1.870)独立相关。
- 术中凝血紊乱(ISTH-DIC评分升高)与30天死亡率(OR=2.705,95%CI 1.108-6.606)和长期死亡率(HR=1.381,95%CI 1.049-1.817)独立相关。
- 肝功能障碍与长期死亡率独立相关(HR=7.653,95%CI 2.031-28.842),Charlson合并症指数亦与长期死亡率相关(HR=1.330,95%CI 1.041-1.699)。
- SAPS II评分与30天死亡率独立相关(OR=1.056,95%CI 1.010-1.1041)。
适用人群与场景
- 成人癌症患者,因择期或急诊肿瘤手术进入手术室并发生术中失血性休克。
- 研究在癌症转诊中心进行,纳入时间为2013年1月至2018年2月。
研究设计与关键结果
- 回顾性研究,纳入84例成人癌症患者,均为术中发生失血性休克的肿瘤手术患者。
- 30天死亡率为26%(22例),从ICU入住起平均随访20个月(95%CI 15-25个月),期间39例(46%)死亡。
- 多因素logistic回归显示与30天死亡率独立相关的因素:SAPS II评分(OR=1.056,95%CI 1.010-1.1041)、delta SOFA(第3天SOFA评分减第1天SOFA评分)(OR=1.780,95%CI 1.184-2.677)、ISTH-DIC评分(OR=2.705,95%CI 1.108-6.606)。
- Cox多因素分析显示与长期死亡率相关的因素:delta SOFA(HR=1.558,95%CI 1.298-1.870)、ISTH-DIC评分(HR=1.381,95%CI 1.049-1.817)、肝功能障碍(HR=7.653,95%CI 2.031-28.842)、Charlson合并症指数(HR=1.330,95%CI 1.041-1.699)。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,应评估早期围手术期集束化策略以改善此类肿瘤手术术中失血性休克患者的生存。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Management of hemorrhagic shock is well codified by international guidelines. These guidelines are predominantly based on trauma patients. We aimed to evaluate factors associated with 30-day mortality and long-term survival after intraoperative hemorrhagic shock during major oncological surgery.
METHODS: This retrospective study was conducted in a cancer referral center from January 2013 to February 2018. All adult cancer patients admitted in the operative room for scheduled or emergency oncological surgery associated with an intraoperative hemorrhagic shock were included.
RESULTS: Eighty-four patients were included in this study. The 30-day mortality rate was 26% (n = 22), the mean follow-up from the time of ICU admission was 20 months (95% CI, 15-25 months), 39 (46%) patients died during this period. Using logistic regression for multivariate analysis, factors independently associated with 30-day mortality were SAPS II score (odds ratio (OR) =1.056, 95% confident interval (CI) =1.010-1.1041), delta SOFA (SOFA score at day 3 - SOFA score at day 1) (OR= 1.780, 95% CI 1.184-2.677) and ISTH-DIC score (OR = 2.705, 95% CI 1.108-6.606). Using Cox multivariate analysis, factors associated with long-term mortality were delta SOFA (hazard ratio (HR) =1.558, 95% CI 1.298-1.870), ISTH-DIC score (HR = 1.381, 95% CI 1.049-1.817), hepatic dysfunction (HR = 7.653, 95% CI 2.031-28.842), and Charlson comorbidity index (HR = 1.330, 95% CI 1.041-1.699).
CONCLUSION: The worsening of organ dysfunctions during the first 3 days of ICU admission as well as intraoperative coagulation disturbances (increased ISTH-DIC score) are independently associated with short and long-term mortality. Comorbidities (Charlson comorbidity index) and postoperative hepatic dysfunction were independently associated with long-term mortality. Early perioperative bundle strategies should be evaluated in order to improve patient's survival in this specific situation.
参考来源
- Hamon A, Mokart D, Pouliquen C, et al. Intraoperative Hemorrhagic Shock in Cancer Surgical Patients: Short and Long-Term Mortality and Associated Factors. Shock. 2020. PMID: 32205792. doi:10.1097/SHK.0000000000001537
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。